2,3,7,8-Tetrachlorodibenzo-p-dioxin abolishes circadian regulation of hepatic metabolic activity in mice

Abstract Aryl hydrocarbon receptor (AhR) activation is reported to alter the hepatic expression of circadian clock regulators, however the impact on clock-controlled metabolism has not been thoroughly investigated. This study examines the effects of AhR activation on hepatic transcriptome and metabo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kelly A. Fader, Rance Nault, Claire M. Doskey, Russell R. Fling, Timothy R. Zacharewski
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
R
Q
Acceso en línea:https://doaj.org/article/9a17274562514ae6a763ae55659ce0bb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9a17274562514ae6a763ae55659ce0bb
record_format dspace
spelling oai:doaj.org-article:9a17274562514ae6a763ae55659ce0bb2021-12-02T15:09:14Z2,3,7,8-Tetrachlorodibenzo-p-dioxin abolishes circadian regulation of hepatic metabolic activity in mice10.1038/s41598-019-42760-32045-2322https://doaj.org/article/9a17274562514ae6a763ae55659ce0bb2019-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-019-42760-3https://doaj.org/toc/2045-2322Abstract Aryl hydrocarbon receptor (AhR) activation is reported to alter the hepatic expression of circadian clock regulators, however the impact on clock-controlled metabolism has not been thoroughly investigated. This study examines the effects of AhR activation on hepatic transcriptome and metabolome rhythmicity in male C57BL/6 mice orally gavaged with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) every 4 days for 28 days. TCDD diminished the rhythmicity of several core clock regulators (e.g. Arntl, Clock, Nr1d1, Per1, Cry1, Nfil3) in a dose-dependent manner, involving either a ≥ 3.3-fold suppression in amplitude or complete loss of oscillation. Accordingly, protein levels (ARNTL, REV-ERBα, NFIL3) and genomic binding (ARNTL) of select regulators were reduced and arrhythmic following treatment. As a result, the oscillating expression of 99.6% of 5,636 clock-controlled hepatic genes was abolished including genes associated with the metabolism of lipids, glucose/glycogen, and heme. For example, TCDD flattened expression of the rate-limiting enzymes in both gluconeogenesis (Pck1) and glycogenesis (Gys2), consistent with the depletion and loss of rhythmicity in hepatic glycogen levels. Examination of polar hepatic extracts by untargeted mass spectrometry revealed that virtually all oscillating metabolites lost rhythmicity following treatment. Collectively, these results suggest TCDD disrupted circadian regulation of hepatic metabolism, altering metabolic efficiency and energy storage.Kelly A. FaderRance NaultClaire M. DoskeyRussell R. FlingTimothy R. ZacharewskiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 9, Iss 1, Pp 1-18 (2019)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Kelly A. Fader
Rance Nault
Claire M. Doskey
Russell R. Fling
Timothy R. Zacharewski
2,3,7,8-Tetrachlorodibenzo-p-dioxin abolishes circadian regulation of hepatic metabolic activity in mice
description Abstract Aryl hydrocarbon receptor (AhR) activation is reported to alter the hepatic expression of circadian clock regulators, however the impact on clock-controlled metabolism has not been thoroughly investigated. This study examines the effects of AhR activation on hepatic transcriptome and metabolome rhythmicity in male C57BL/6 mice orally gavaged with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) every 4 days for 28 days. TCDD diminished the rhythmicity of several core clock regulators (e.g. Arntl, Clock, Nr1d1, Per1, Cry1, Nfil3) in a dose-dependent manner, involving either a ≥ 3.3-fold suppression in amplitude or complete loss of oscillation. Accordingly, protein levels (ARNTL, REV-ERBα, NFIL3) and genomic binding (ARNTL) of select regulators were reduced and arrhythmic following treatment. As a result, the oscillating expression of 99.6% of 5,636 clock-controlled hepatic genes was abolished including genes associated with the metabolism of lipids, glucose/glycogen, and heme. For example, TCDD flattened expression of the rate-limiting enzymes in both gluconeogenesis (Pck1) and glycogenesis (Gys2), consistent with the depletion and loss of rhythmicity in hepatic glycogen levels. Examination of polar hepatic extracts by untargeted mass spectrometry revealed that virtually all oscillating metabolites lost rhythmicity following treatment. Collectively, these results suggest TCDD disrupted circadian regulation of hepatic metabolism, altering metabolic efficiency and energy storage.
format article
author Kelly A. Fader
Rance Nault
Claire M. Doskey
Russell R. Fling
Timothy R. Zacharewski
author_facet Kelly A. Fader
Rance Nault
Claire M. Doskey
Russell R. Fling
Timothy R. Zacharewski
author_sort Kelly A. Fader
title 2,3,7,8-Tetrachlorodibenzo-p-dioxin abolishes circadian regulation of hepatic metabolic activity in mice
title_short 2,3,7,8-Tetrachlorodibenzo-p-dioxin abolishes circadian regulation of hepatic metabolic activity in mice
title_full 2,3,7,8-Tetrachlorodibenzo-p-dioxin abolishes circadian regulation of hepatic metabolic activity in mice
title_fullStr 2,3,7,8-Tetrachlorodibenzo-p-dioxin abolishes circadian regulation of hepatic metabolic activity in mice
title_full_unstemmed 2,3,7,8-Tetrachlorodibenzo-p-dioxin abolishes circadian regulation of hepatic metabolic activity in mice
title_sort 2,3,7,8-tetrachlorodibenzo-p-dioxin abolishes circadian regulation of hepatic metabolic activity in mice
publisher Nature Portfolio
publishDate 2019
url https://doaj.org/article/9a17274562514ae6a763ae55659ce0bb
work_keys_str_mv AT kellyafader 2378tetrachlorodibenzopdioxinabolishescircadianregulationofhepaticmetabolicactivityinmice
AT rancenault 2378tetrachlorodibenzopdioxinabolishescircadianregulationofhepaticmetabolicactivityinmice
AT clairemdoskey 2378tetrachlorodibenzopdioxinabolishescircadianregulationofhepaticmetabolicactivityinmice
AT russellrfling 2378tetrachlorodibenzopdioxinabolishescircadianregulationofhepaticmetabolicactivityinmice
AT timothyrzacharewski 2378tetrachlorodibenzopdioxinabolishescircadianregulationofhepaticmetabolicactivityinmice
_version_ 1718387891028099072